Cite
HARVARD Citation
Kayser, S. et al. (2017). Clinical impact of KMT2C and SPRY4 expression levels in intensively treated younger adult acute myeloid leukemia patients. European journal of haematology. pp. 544-552. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Kayser, S. et al. (2017). Clinical impact of KMT2C and SPRY4 expression levels in intensively treated younger adult acute myeloid leukemia patients. European journal of haematology. pp. 544-552. [Online].